iShares Nasdaq US Biotechnology UCITS ETF
Performance comparison
Total return, rebased to 0% at the start of the period
- BTECiShares Nasdaq US Biotechnology UCITS ETF+8.4%
| Fund | Return | Annualised | Volatility | Max drawdown | Up days | TER | Fund size |
|---|---|---|---|---|---|---|---|
| BTEC | +8.4% | +8.4% | 16.0% | -14.3% | 50% | 0.35% | €400M |
Simulated series for illustration: each fund follows a seeded path with volatility and drift typical of its theme, sharing one market factor so related funds move together. Figures are approximate and not a record of real prices or past performance. Volatility is annualised from daily returns; drawdown is the worst peak-to-trough fall inside the window.
Documents & issuer links
Sample links — demo data- KID (Key Information Document)Two-page regulatory summary: risk score, costs, past performance · issuer site
- ProspectusFull legal terms of the fund and its umbrella company · issuer site
- FactsheetMonthly one-pager with performance, sectors and top holdings · issuer site
- Annual reportAudited accounts, securities lending revenue and full holdings · issuer site
- Index methodologyHow the benchmark selects, weights and rebalances constituents · issuer site
- Full holdings (CSV)Every position with weights, published daily by the issuer · issuer site
Always read the KID and prospectus on the issuer’s own site before buying BTEC. ETFPanda is not affiliated with iShares.
WEEKWeekly World Equity Income UCITS ETF
Europe’s first weekly-paying ETF · HANetf · LSE
Fund profile
Sample reference data- Benchmark index
- Nasdaq Biotechnology Index
- Index provider
- Nasdaq
- Replication
- Physical — full replication, optimised sampling on the long tail
- Rebalancing
- Annually
- Securities lending
- Not used by this share class
- Legal structure
- Open-ended ICAV / plc sub-fund
- Domicile
- Ireland
- UCITS
- Yes — UCITS V compliant
- SFDR classification
- Article 6 — no sustainability objective
- Income treatment
- Accumulating — income reinvested inside the fund
- Distribution frequency
- None — reinvested
- Currency hedging
- No — unhedged, currency risk is carried by the investor
- Withholding tax
- 15% US treaty rate on US dividends, no Irish withholding on payouts
- UK reporting status
- No
- Savings plans
- Available at most German and Austrian brokers
- Share class launch
- November 2016
- Fiscal year end
- 30 June
- Depositary / custodian
- State Street Custodial Services (Ireland)
Listings & identifiers
Sample cross-listings| Exchange | Ticker | Trading currency | Listing |
|---|---|---|---|
| Xetra | BTEC | EUR | Primary |
| SIX Swiss | BTEC | CHF | Cross-listing |
| Euronext Amsterdam | BTEC | EUR | Cross-listing |
Top holdings
Top 10 = 65.1% of the fund · sample data- 1Amgen10.41%
- 2Gilead Sciences9.26%
- 3Vertex Pharmaceuticals8.24%
- 4Regeneron7.34%
- 5Moderna6.53%
- 6Alnylam Pharmaceuticals5.81%
- 7BioMarin5.17%
- 8Incyte4.60%
- 9United Therapeutics4.10%
- 10Neurocrine3.65%
268 positions in total — the remaining 34.9% sits in the long tail.
Risk, return & total cost
Sample figures — not investment adviceWhat you actually pay each year
- Ongoing charge (TER)
- 0.35%
- Portfolio transaction costs
- 0.04%
- of which index licence fee
- 0.03%
- Estimated total cost
- 0.39%
Excludes your broker’s commission and the bid–ask spread you pay on the way in and out.
Sticky placement — stays in view while readers scroll.
Book this spaceWhere to buy BTEC
Brokers where you can buy iShares Nasdaq US Biotechnology UCITS ETF on Xetra, in our editorial ranking. Compare order fees, custody charges and savings-plan terms before you place the order.
| Broker | Rating | ETF order fee | Custody fee | Savings plans | Offer |
|---|---|---|---|---|---|
Trade RepublicTop pick The savings-plan machine — €1 trades and free recurring ETF investing with a full bank licence. | 4.6 | €1 flat | €0 | Free, from €1/month Fractional shares | Read review — Trade Republic, to buy BTEC |
The professional's choice — unmatched market access at institutional pricing. | 4.5 | From ~€1.25 (tiered) | €0 | Recurring investments, no fee Fractional shares | Read review — Interactive Brokers, to buy BTEC |
A clean, multi-currency challenger built for European index investors. | 4.1 | €0 on ETF list | €0 | AutoInvest, free Fractional shares | Read review — Lightyear, to buy BTEC |
- Trade RepublicTop pickThe savings-plan machine — €1 trades and free recurring ETF investing with a full bank licence.4.6
- Order fee
- €1 flat
- Custody
- €0
- Savings plans
- Free, from €1/month
- The professional's choice — unmatched market access at institutional pricing.4.5
- Order fee
- From ~€1.25 (tiered)
- Custody
- €0
- Savings plans
- Recurring investments, no fee
- A clean, multi-currency challenger built for European index investors.4.1
- Order fee
- €0 on ETF list
- Custody
- €0
- Savings plans
- AutoInvest, free
* Partner link: if you open an account through it we may earn a commission, at no extra cost to you. It never affects a broker’s score or position. Fees shown are indicative and were last reviewed August 2026; confirm current terms with the broker before trading.